Treatment options for apnoea of prematurity

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 101, Issue 4, 2016, Pages F352-F356

  Morton, Sarah U ^a   Smith, Vincent C ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPHYLLINE; AMPAKINE; ANTIOXIDANT; CAFFEINE; CARBON DIOXIDE; DOXAPRAM; OXYGEN; THEOPHYLLINE; UNCLASSIFIED DRUG; XANTHINE DERIVATIVE;

ACIDOSIS; BRAIN FUNCTION; DISEASE SEVERITY; ERYTHROCYTE TRANSFUSION; GASTROESOPHAGEAL REFLUX; HYPERCAPNIA; INTERMITTENT HYPOXIA; LUNG MECHANICS; NEWBORN APNEA; NONHUMAN; PARTIAL PRESSURE; PATHOPHYSIOLOGY; PERINATAL PERIOD; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; PRIORITY JOURNAL; RESPIRATION CONTROL; RESPIRATORY TRACT INFLAMMATION; REVIEW; APNEA; DISEASE MANAGEMENT; HUMAN; INFANT, PREMATURE, DISEASES; NEWBORN;

APNEA; DISEASE MANAGEMENT; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES;

EID: 84973161301     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/archdischild-2015-310228     Document Type: Review

References (41)

1. Williamson JR, Bliss DW, Paydarfar D. Forecasting respiratory collapse: theory and practice for averting life-threatening infant apneas. Respir Physiol Neurobiol 2013;189:223-31.
2. Eichenwald EC. Committee on Fetus and Newborn. Apnea of prematurity. Pediatrics 2016;137:1-7.
3. Mathew OP. Apnea of prematurity: pathogenesis and management strategies. J Perinatol 2011;31:302-10.
4. Di Fiore JM, Martin RJ, Gauda EB. Apnea of prematurity - Perfect storm. Respir Physiol Neurobiol 2013;189:213-22.
5. Huxtable AG, Smith SM, Peterson TJ, et al. Intermittent hypoxia-induced spinal inflammation impairs respiratory motor plasticity by a spinal p38 MAP Kinase-dependent mechanism. J Neurosci 2015;35:6871-80.
6. Pawar A, Peng YJ, Jacono FJ, et al. Comparative analysis of neonatal and adult rat carotid body responses to chronic intermittent hypoxia. J Appl Physiol 2008;104:1287-94.
7. Master ZR, Kesavan K, Mason A, et al. Effect of Lipopolysaccharide Exposure on Structure and Function of the Carotid Body in Newborn Rats. Adv Exp Med Biol 2015;860:115-21.
8. Nanduri J, Prabhakar NR. Epigenetic regulation of carotid body oxygen sensing: clinical implications. Adv Exp Med Biol 2015;860:1-8.
9. Bloch-Salisbury E, Hall MH, Sharma P, et al. Heritability of apnea of prematurity: a retrospective twin study. Pediatrics 2010;126:e779-87.
10. Amin SB, Wang H. Unbound unconjugated hyperbilirubinemia is associated with central apnea in premature infants. J Pediatr 2015;166:571-5.
11. Schoen K, Yu T, Stockmann C, et al. Use of Methylxanthine therapies for the treatment and prevention of apnea of prematurity. Paediatr Drugs 2014;16:169-77.
12. Kraaijenga JV, Hutten GJ, de Jongh FH, et al. The effect of Caffeine on diaphragmatic activity and tidal volume in preterm infants. J Pediatr 2015;167:70-5.
13. Lodha A, Seshia M, McMillan DD, et al. Association of early caffeine administration and neonatal outcomes in very preterm neonates. JAMA Pediatr 2015;169:33-8.
14. Hoecker C, Nelle M, Poeschl J, et al. Caffeine impairs cerebral and intestinal blood flow velocity in preterm infants. Pediatrics 2002;109:784-7.
15. Saliba E, Autret E, Gold F, et al. Effect of caffeine on cerebral blood flow velocity in preterm infants. Biol Neonate 1989;56:198-203.
16. Mohammed S, Nour I, Shabaan AE. High versus low-dose caffeine for apnea of prematurity: a randomized controlled trial. Eur J Pediatr 2015;174:949-56.
17. Alur P, Bollampalli V, Bell T, et al. Serum caffeine concentrations and short-term outcomes in premature infants of ≤29 weeks of gestation. J Perinatol 2015;35:434-8.
18. Rhein LM, Dobson NR, Darnall RA, et al. Effects of caffeine on intermittent hypoxia in infants born prematurely: a randomized clinical trial. JAMA Pediatr 2014;168:250-7.
19. Doyle J, Davidson D, Katz S, et al. Apnea of prematurity and caffeine pharmacokinetics: potential impact on hospital discharge. J Perinatol 2016;36:141-4.
20. Schmidt B, Roberts RS, Davis P, et al. Caffeine therapy for apnea of prematurity. N Engl J Med 2006;354:2112-21.
21. Janvier A, Khairy M, Kokkotis A, et al. Apnea is associated with neurodevelopmental impairment in very low birth weight infants. J Perinatol 2004;24:763-8.
22. Schmidt B, Anderson PJ, Doyle LW, et al. Survival without disability to age 5 Years after neonatal caffeine therapy for apnea of prematurity. JAMA 2015;307:275-82.
23. Doyle LW, Schmidt B, Anderson PJ, et al. Reduction in developmental coordination disorder with neonatal caffeine therapy. J Pediatr 2014;165:356-359.e2.
24. Laubscher B, Greenough A, Dimitriou G. Comparative effects of theophylline and caffeine on respiratory function of prematurely born infants. Early Hum Dev 1998;50:185-92.
25. Tey SL, Lee WT, Lee PL, et al. Neurodevelopmental outcomes in very low birth weight infants using aminophylline for the treatment of apnea. Pediatr Neonatol 2016;57:41-6.
26. Prins SA, Pans SJ, van Weissenbruch MM, et al. Doxapram use for apnoea of prematurity in neonatal intensive care. Int J Pediatr 2013;2013:251047.
27. Czaba-Hnizdo C, Olischar M, Rona Z, et al. Amplitude-integrated electroencephalography shows that doxapram influences the brain activity of preterm infants. Acta Paediatr 2014;103:922-7.
28. Ren J, Ding X, Greer JJ. Ampakines enhance weak endogenous respiratory drive and alleviate apnea in perinatal rats. Am J Respir Crit Care Med 2015;191:704-10.
29. Oertel BG, Felden L, Tran PV, et al. Selective antagonism of opioid-induced ventilatory depression by an ampakine molecule in humans without loss of opioid analgesia. Clin Pharmacol Ther 2010;87:204-11.
30. Vandenplas Y, Salvatore S, Devreker T, et al. Gastro-oesophageal reflux disease: oesophageal impedance versus pH monitoring. Acta Paediatr 2007;96:956-62.
31. Abu Jawdeh EG, Martin RJ. Neonatal apnea and gastroesophageal reflux (GER): is there a problem? Early Hum Dev 2013;89(Suppl 1):S14-16.
32. Ho T, Dukhovny D, Zupancic JA, et al. Choosing wisely in Newborn medicine: five opportunities to increase value. Pediatrics 2015;136:e482-489.
33. Claure N, Bancalari E, D'Ugard C, et al. Multicenter crossover study of automated control of inspired oxygen in ventilated preterm infants. Pediatrics 2011;127:e76-83.
34. Alvaro RE, Khalil M, Qurashi M, et al. CO(2) Inhalation as a treatment for apnea of prematurity: a randomized double-blind controlled trial. J Pediatr 2012;160:252-7.e1.
35. Gizzi C, Montecchia F, Panetta V, et al. Is synchronised NIPPV more effective than NIPPV and NCPAP in treating apnoea of prematurity (AOP)? A randomised cross-over trial. Arch Dis Child Fetal Neonatal Ed 2015;100:F17-23.
36. Camargo VC, Honorato da Silva S, Freitas de Amorim M, et al. Instrumentation for the detection and interruption of apnea episodes for premature newborn. Conf Proc IEEE Eng Med Biol Soc 2014;2014:2127-30.
37. Smith VC, Kelty-Stephen D, Qureshi Ahmad M, et al. Stochastic resonance effects on apnea, Bradycardia, and Oxygenation: a randomized controlled trial. Pediatrics 2015;136:e1561-8.
38. Zagol K, Lake DE, Vergales B, et al. Anemia, apnea of prematurity, and blood transfusions. J Pediatr 2012;161:417-421.e1.
39. Abu Jawdeh EG, Martin RJ, Dick TE, et al. The effect of red blood cell transfusion on intermittent hypoxemia in ELBW infants. J Perinatol 2014;34:921-5.
40. Eichenwald EC. Apnea, intermittent hypoxia and blood transfusions: it works, but now what? J Perinatol 2014;34:881.
41. Butler TJ, Firestone KS, Grow JL, et al. Standardizing documentation and the clinical approach to apnea of prematurity reduces length of stay, improves staff satisfaction, and decreases hospital cost. Jt Comm J Qual Patient Saf 2014;40:263-9.